Chapter 6: Meeting industry requirements

Download chapter (PDF 452kb)

Chapter at a glance

  • We have sought to design a mechanism to which industry will respond by increasing R&D on vaccines for diseases occurring mainly in developing countries.
  • Industry is attracted to the concept of payment for results; the market mechanism fits their business model well and preserves the role of intellectual property rights and market sales financing commercial investment in pharmaceutical R&D.
  • Our consultations revealed a range of priorities for the commitment from different parts of industry.
  • An advance market commitment would be of value to developingcountry suppliers, which often do not benefit from other incentive arrangements.
  • Complementary measures are needed to improve the procurement of existing vaccines, improve demand forecasts and increase funding for existing drugs and vaccines.

Read full chapter (PDF 452kb)